Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.64 EUR | +0.14% | +1.95% | +103.33% |
17/04 | Medincell: share price rises following agreement with AbbVie | CF |
16/04 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+103.33% | 453M | |
+31.52% | 690B | |
+24.87% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.17% | 235B | |
+5.41% | 199B | |
-9.98% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- France's Medincell Names New Chief Medical Officer